Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT03874052 · RECRUITING

Trial details

NCT number: NCT03874052
Sponsor: Jennifer Saultz
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Recurrent Secondary Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Secondary Acute Myeloid Leukemia

Start date: 2019-08-16
Primary completion: 2027-12-31
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.